Li Xin, Zhou Lingying, Gorodeski George I
Department of Reproductive Biology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Endocrinology. 2006 Nov;147(11):5236-48. doi: 10.1210/en.2006-0779. Epub 2006 Aug 10.
The objective of the study was to understand how estrogen modulates the rigidity of the cytoskeleton in epithelial cells. Estrogen depletion decreased, and treatment with 17beta-estradiol increased deformability of cervical-vaginal epithelial cells. Estrogen also induced redistribution of nonmuscle myosin II-B (NMM-II-B); lesser interaction of NMM-II-B with actin; increased phosphorylation of NMM-II-B-heavy chains at threonine and serine residues; and decreased filamentation of NMM-II-B in vitro. The effects of 17beta-estradiol were time and dose related and could be mimicked by diethylstilbestrol. The effects of estrogen were blocked by cotreatment with antisense oligonucleotide for the estrogen receptor-alpha and inhibited by ICI-182,780 and tamoxifen; omission of epithelial growth factor (EGF) from the culture medium; and cotreatments with the EGF receptor inhibitor AG1478, the ERK-MAPK inhibitor PD98059, the casein kinase-II (CK2) inhibitor 5,6-dichloro-1-beta-(D)-ribofuranosylbenzimidazole, the Rho-associated kinase inhibitor Y-27632, and the nonspecific phosphatase inhibitor okadaic acid. Coadministration of 5,6-dichloro-1-beta-(D)-ribofuranosylbenzimidazole plus okadaic acid blocked the 17beta-estradiol effect. H-89 or LY294002 did not significantly affect estrogen effects. Treatment with estrogen increased activation of ERK1/2 and CK2 activity. These data suggest a novel pathway of estrogen regulation of the cytoskeleton in epithelial cells. The effect is mediated by estrogen receptor-alpha and involves in part the EGF-EGF receptor and ERK-MAPK cascades as proximal signaling networks and the CK2 and Rho-associated kinase-regulated myosin heavy chain phosphatase as terminal effectors. Augmented phosphorylation of NMM-II-B can block filamentation and induce disassociation of the myosin from the cortical actin, and disruption of the actomyosin ring can increase cell deformability. This mechanism can explain estrogen regulation of paracellular permeability in cervical-vaginal epithelia in vivo.
该研究的目的是了解雌激素如何调节上皮细胞中细胞骨架的刚性。雌激素耗竭会降低宫颈 - 阴道上皮细胞的变形能力,而用17β - 雌二醇处理则会增加其变形能力。雌激素还会诱导非肌肉肌球蛋白II - B(NMM - II - B)重新分布;减少NMM - II - B与肌动蛋白的相互作用;增加NMM - II - B重链在苏氨酸和丝氨酸残基处的磷酸化;并在体外减少NMM - II - B的丝状化。17β - 雌二醇的作用具有时间和剂量依赖性,且己烯雌酚可模拟其作用。雌激素的作用可被雌激素受体α反义寡核苷酸共处理阻断,并被ICI - 182,780和他莫昔芬抑制;培养基中上皮生长因子(EGF)的缺失;以及与EGF受体抑制剂AG1478、ERK - MAPK抑制剂PD98059、酪蛋白激酶 - II(CK2)抑制剂5,6 - 二氯 - 1 - β - (D) - 呋喃核糖基苯并咪唑、Rho相关激酶抑制剂Y - 27632和非特异性磷酸酶抑制剂冈田酸共处理。5,6 - 二氯 - 1 - β - (D) - 呋喃核糖基苯并咪唑与冈田酸联合给药可阻断17β - 雌二醇的作用。H - 89或LY294002对雌激素的作用无显著影响。雌激素处理可增加ERK1/2的激活和CK2活性。这些数据表明雌激素调节上皮细胞中细胞骨架存在一条新途径。该作用由雌激素受体α介导,部分涉及EGF - EGF受体和ERK - MAPK级联作为近端信号网络,以及CK2和Rho相关激酶调节的肌球蛋白重链磷酸酶作为终末效应器。NMM - II - B磷酸化增强可阻断丝状化并诱导肌球蛋白与皮质肌动蛋白解离,肌动球蛋白环的破坏可增加细胞变形能力。这一机制可解释雌激素在体内对宫颈 - 阴道上皮细胞旁通透性的调节作用。